UCLA Health Jonsson Comprehensive Cancer Center

In the late 1960s, a group of scientists, clinicians, and volunteers at UCLA came together to develop a cancer center they hoped would become renowned for excellence in research, education, and patient care. Since that time, the UCLA Health Jonsson Comprehensive Cancer Center (UCLA Health JCCC) has become a global leader in cancer research, education and training, and clinical care with a mission to accelerate discoveries to prevent and cure cancer.

The UCLA Health JCCC attained designation as a "comprehensive cancer center" by the National Cancer Institute (NCI) in 1976, a testament to its sustained excellence in cancer research, education, and outreach into Los Angeles County communities and well beyond. A strong partnership with UCLA Health provides outstanding cancer patient care, prevention, and survivorship. 

At UCLA Health, teams of specialists work together to treat and assist cancer patients and their families. A multidisciplinary approach helps patients and family members confront both the immediate and long-term effects of cancer. As an NCI-designated comprehensive cancer center, the UCLA Health JCCC works to reduce or eliminate disparities in the burden of cancer, to ensure that all share equally in the medical advances that result from cancer research.

The UCLA Health JCCC has an international reputation for developing new cancer therapies, providing the best in experimental and traditional treatments. Center members conduct research on a wide range of cancers and the Center offers patients the opportunity to participate in clinical trials and research. The UCLA Health JCCC has over 500 active cancer clinical trials at any given time that are enrolling patients, and offers many of these trials not only to residents of  Los Angeles County but at partner institutions and affiliate sites across the country.

With more than 500 physicians and scientists, the UCLA Health JCCC is one of the largest comprehensive cancer centers in the nation. With an international reputation for providing the best in experimental and traditional cancer treatments, UCLA Health JCCC experts also train and educate the next generation of medical researchers. Successful targeted cancer therapies such as trastuzumab, imatinib, enzalutamide, and others were developed from basic studies performed in Center laboratories and brought to clinical trials for UCLA cancer patients.

For 24 consecutive years, the UCLA Health Jonsson Comprehensive Cancer Center has been recognized as one of the best locations in the country to receive cancer care, according to the U.S. News & World Report national honor roll. In 2023, the U.S. News best hospital specialty rankings named the UCLA Health Jonsson Comprehensive Cancer Center No. 1 in both California and the Los Angeles metropolitan area, and No. 4 in hospital cancer care in the country.

The UCLA Health JCCC is also one of 33 leading cancer centers in the United States participating in the National Comprehensive Cancer Network (NCCN). As a NCCN member, UCLA Health JCCC experts join experts from other Centers in setting the standards for diagnosing and treating patients with cancer, with a particular focus on uncommon, complex, or aggressive forms of the disease.

To learn more about the UCLA Health Jonsson Comprehensive Cancer Center and connect with its faculty and staff, please visit uclahealth.org/cancer.